Altimmune, Inc. (ALT) CEO Vipin Garg on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
Altimmune Announces First Quarter 2020 Financial Results and Provides a Business UpdateGlobeNewsWire • 05/13/20
Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of DirectorsGlobeNewsWire • 05/12/20
COVID-19 Vaccine Updates: J&J Identifies Lead Candidate, IMV Eyes Clinical Testing In Summer, Altimmune Partners With University Of AlabamaBenzinga • 03/30/20
Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 VaccineGlobeNewsWire • 03/30/20
Altimmune's Coronavirus Spike, And Other News: The Good, Bad, And Ugly Of BiopharmaSeeking Alpha • 03/04/20
Altimmune Announces Positive Results for ALT-702 in Preclinical Model of Colorectal CancerGlobeNewsWire • 01/23/20
Altimmune's (ALT) CEO Vipin Garg on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™ Clinical DevelopmentGlobeNewsWire • 08/21/19
Altimmune, Inc. (ALT) CEO Vipin Garg on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/14/19
Altimmune's stock soars after adding NASH candidate with purchase of Spitfire PharmaMarket Watch • 07/09/19